{
  "trial_id": "NCT01141751",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Subjects eligible for Rebif therapy according to indications and clinical use in the",
      "label": "met",
      "evidence": "Rebif Product Monograph"
    },
    {
      "criterion": "Subjects who have read, understood, signed and dated the informed consent form",
      "label": "met",
      "evidence": "informed consent form"
    }
  ],
  "exclusion": [
    {
      "criterion": "Subjects who are unable to fill in the questionnaires by him/herself",
      "label": "unknown",
      "evidence": "none"
    },
    {
      "criterion": "Subjects who have used disease modifying drugs within the last month (or 30 days)",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "The patient has RRMS and is under treatment for 7 months. She smokes 10 cigarettes per day.",
  "_meta": {
    "topic_id": "37",
    "trial_id": "NCT01141751",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}